ClinicalTrials.Veeva

Menu
H

Hospital Sultan Abdul Halim | Clinical Research Centre

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Empagliflozin
Cefazolin
sulfamethoxazole
Clindamycin
Cephalexin
Ceftaroline
Apixaban
Trimethoprim
Vancomycin
JNJ-64179375

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 6 total trials

EMPA-KIDNEY (The Study of Heart and Kidney Protection With Empagliflozin)

The primary aim of the study is to investigate the effect of empagliflozin on kidney disease progression or cardiovascular death versus placebo on to...

Active, not recruiting
Chronic Kidney Disease
Drug: Matching placebo
Drug: Empagliflozin

This study is conducted to see if ziltivekimab reduces the risk of having cardiovascular events (for example heart attack and stroke) in people with...

Enrolling
Chronic Kidney Disease
Inflammation
Drug: Placebo (Ziltivekimab B)
Drug: Placebo (Ziltivekimab C)

Trial sponsors

Boehringer Ingelheim logo
Janssen (J&J Innovative Medicine) logo
L
Novo Nordisk logo
C
U

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems